Please sign in to follow a disease.
Which hand rub saves more tiny lives? new trial aims to find out
NCT ID NCT07421323
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two common hand rubs—chlorhexidine and alcohol—used by medical staff before touching premature babies in the NICU. The goal is to see which one better prevents healthcare-associated infections. One hundred premature infants will be monitored with blood cultures at 7, 14, and 28 days after birth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- chlorhexidine gluconate and alcohol hand rubs
- What this could lead to
- If this trial shows one hand rub is better, it could lead to simple changes in hand hygiene that reduce infections in vulnerable newborns.
- What could go wrong
- This is a small, early-stage study with only 100 babies, so results may not apply to all hospitals. The outcome depends on staff following the hand rub routine consistently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 hours to 1 day
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Neonates \<37 weeks gestational age admitted to NICU of Alexandria University Children's Hospitals Exclusion Criteria: * Patients with any of the following will be excluded: 1. Obvious major congenital abnormalities, immunodeficiency and inborn error of metabolism. 2. Early onset sepsis (before the third day). 3. Infants more than 72 hours of age at the time of randomization. 4. Parental consent lacking/refusal.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthcare associated infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Marwa Mohamed Farag
RECRUITINGAlexandria, 0325, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sepsis in newborns: the hidden brain signs doctors may be missing
- Could a higher steroid dose help preterm babies breathe easier?
- Quick blood tests could save newborns from sepsis
- Hospitals team up to solve mystery of Hard-to-Treat lung infections
- Hospital maps may slash infection spread
- Kidney injury prediction study for sick kids withdrawn before starting